Dld Asset Management, LP Relmada Therapeutics, Inc. Transaction History
Dld Asset Management, LP
- $632 Million
- Q1 2025
A detailed history of Dld Asset Management, LP transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Dld Asset Management, LP holds 87,400 shares of RLMD stock, worth $54,188. This represents 0.12% of its overall portfolio holdings.
Number of Shares
87,400Holding current value
$54,188% of portfolio
0.12%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RLMD
# of Institutions
49Shares Held
6.3MCall Options Held
0Put Options Held
0-
Acadian Asset Management LLC Boston, MA1.23MShares$761,3150.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$749,0060.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$355,4540.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$306,9900.03% of portfolio
-
Geode Capital Management, LLC Boston, MA302KShares$187,1670.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $17.7M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...